giancarlo la marca

Professore Associato

Università degli Studi di Napoli Federico II

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Giancarlo La Marca is an Associate Professor at the Università degli Studi di Firenze, Italy. His research primarily focuses on newborn screening and metabolic disorders, as evidenced by his recent publications on topics such as pyridoxine dependent epilepsy, inborn errors of immunity, and urea cycle disorders. He actively contributes to the advancement of clinical practices in neonatal care and treatment methodologies.

Articles (12)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Year:

2020

Collaborators (1)

Renzo Guerrini

University of Florence

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

giancarlo la marca

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Inclusion of pyridoxine dependent epilepsy in expanded newborn screening programs by tandem mass spectrometry: set up of first and second tier tests

Enteral and Parenteral Treatment with Caffeine for Preterm Infants in the Delivery Room: A Randomised Trial(vol25, pg79-86, 2023)

Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome

Expanded Newborn Screening for Inborn Errors of Immunity: The Experience of Tuscany

Long-Term Management of Patients with Mild Urea Cycle Disorders Identified through the Newborn Screening: An Expert Opinion for Clinical Practice

Arginine in older patients with persistent atrial fibrillation: A link to endothelial dysfunction?

Blood sulfatides as disease biomarker for metachromatic leukodystrophy: Disease characterization, early diagnosis, and response to treatment

Communicating a Positive Result at Newborn Screening and Parental Distress

Current State and Innovations in Newborn Screening: Continuing to Do Good and Avoid Harm

Enteral and Parenteral Treatment with Caffeine for Preterm Infants in the Delivery Room: A Randomised Trial

The successful inclusion of ADA SCID in Tuscany expanded newborn screening program

A new strategy implementing mass spectrometry in the diagnosis of congenital disorders of n-glycosylation (cdg)

Collaborators (1)

Renzo Guerrini

Make your next move.